Patent assignee · NL · COMPANY

INTERNA TECHNOLOGIES B.V.

9Patents
9Active
9Granted
44Portfolio score

Filing activity: Sep 4, 2012 → Nov 2, 2018

Most-cited patents

PatentTitleAreaCited byStatus
US9682095B2 MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway Chemistry; Metallurgy 3 Active
US10201556B2 Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway Chemistry; Metallurgy 3 Active
US10023868B2 MiRNA for treating diseases and conditions associated with neo-angiogenesis Chemistry; Metallurgy 2 Active
US9944932B2 MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT Chemistry; Metallurgy 2 Active
US9441222B2 MiRNA for treating diseases and conditions associated with neo-angiogenesis Chemistry; Metallurgy 1 Active
US9161947B2 MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT Chemistry; Metallurgy 1 Active
US10174314B2 MiRNA for treating head and neck cancer Chemistry; Metallurgy 0 Active
US11497762B2 MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation Chemistry; Metallurgy 0 Active
US10583149B2 MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.